1-8 of 8
Robert A. Brodsky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is Allogeneic Transplantation for Sickle Cell Disease Still Relevant in the Era of Gene Therapy?

Clinical Trials & Observations
Richard J. Jones, Adetola A. Kassim, Robert A. Brodsky, Michael R DeBaun
Journal: Blood Advances
Blood Adv bloodadvances.2024013693.
https://doi.org/10.1182/bloodadvances.2024013693
Published: 2024
Journal Articles

Evaluating complement dysregulation in livedoid vasculopathy using a functional assay

Harish Eswaran, Shruti Chaturvedi, Robert A. Brodsky, Gloria F. Gerber, Xiang-Zuo Pan, Stephan Moll
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6604–6607.
https://doi.org/10.1182/bloodadvances.2022009142
Published: 2023
Journal Articles

ADP: the missing link between thrombosis and hemolysis

Gloria F. Gerber, Robert A. Brodsky
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6364–6366.
https://doi.org/10.1182/bloodadvances.2023011186
Published: 2023
Journal Articles

C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy

Clinical Trials & Observations
Hridaya Shah, Hang Chen, Xiang-Zuo Pan, Ara Metjian, Robert A. Brodsky, Evan M. Braunstein, Shruti Chaturvedi
Journal: Blood Advances
Blood Adv (2022) 6 (23): 6071–6074.
https://doi.org/10.1182/bloodadvances.2022008395
Published: 2022
Includes: Supplemental data
Journal Articles

Outcomes of a clinician-directed protocol for discontinuation of complement inhibition therapy in atypical hemolytic uremic syndrome

Clinical Trials & Observations
Shruti Chaturvedi, Noor Dhaliwal, Sarah Hussain, Kathryn Dane, Harshvardhan Upreti, Evan M. Braunstein, Xuan Yuan, C. John Sperati, Alison R. Moliterno, Robert A. Brodsky
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1504–1512.
https://doi.org/10.1182/bloodadvances.2020003175
Published: 2021
Journal Articles

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Clinical Trials & Observations
Amy E. DeZern, Marianna L. Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Philip Imus, Ivan Borrello, Nina Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Javier Bolaños-Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1770–1779.
https://doi.org/10.1182/bloodadvances.2020001729
Published: 2020
Includes: Supplemental data
Journal Articles

In vitro evidence of complement activation in transplantation-associated thrombotic microangiopathy

Seth J. Rotz, Nathan Luebbering, Bradley P. Dixon, Eleni Gavriilaki, Robert A. Brodsky, Christopher E. Dandoy, Sonata Jodele, Stella M. Davies
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1632–1634.
https://doi.org/10.1182/bloodadvances.2017008250
Published: 2017
Includes: Supplemental data
Journal Articles

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide

Clinical Trials & Observations
Yvette L. Kasamon, Richard F. Ambinder, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Javier Bolaños-Meade, Mark J. Levis, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, William H. Matsui, Ivan Borrello, Robert A. Brodsky, Richard J. Jones, Leo Luznik
Journal: Blood Advances
Blood Adv (2017) 1 (4): 288–292.
https://doi.org/10.1182/bloodadvances.2016002766
Published: 2017
Includes: Supplemental data